Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Marimed (MRMD) Income from Continuing Operations (2016 - 2025)

Marimed (MRMD) has disclosed Income from Continuing Operations for 15 consecutive years, with 2941000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Income from Continuing Operations fell 197.07% to 2941000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was 17873000.0, a 27.22% decrease, with the full-year FY2024 number at 12168000.0, up 23.93% from a year prior.
  • Income from Continuing Operations was 2941000.0 for Q3 2025 at Marimed, down from 1270000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 7588892.0 in Q2 2021 to a low of 10128000.0 in Q4 2023.
  • A 5-year average of 871479.37 and a median of 990000.0 in 2024 define the central range for Income from Continuing Operations.
  • Peak YoY movement for Income from Continuing Operations: surged 764.97% in 2021, then tumbled 319.5% in 2025.
  • Marimed's Income from Continuing Operations stood at 6398000.0 in 2021, then soared by 174.23% to 4749000.0 in 2022, then plummeted by 313.27% to 10128000.0 in 2023, then increased by 18.62% to 8242000.0 in 2024, then skyrocketed by 64.32% to 2941000.0 in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Income from Continuing Operations are 2941000.0 (Q3 2025), 1270000.0 (Q2 2025), and 5420000.0 (Q1 2025).